Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nordicus Partners Corp (NORD)

Nordicus Partners Corp (NORD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 75,784
  • Shares Outstanding, K 18,946
  • Annual Sales, $ 10 K
  • Annual Income, $ -2,900 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta -1.07
  • Price/Sales 17,240.86
  • Price/Cash Flow N/A
  • Price/Book 1.31
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.28
  • Most Recent Earnings $-0.08 on 11/14/25
  • Next Earnings Date 04/01/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Business Services
  • INDUSTRY GROUPING Business Services

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/17
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.14
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.9075 unch
on 01/21/26
5.0667 -22.88%
on 12/24/25
-0.2925 (-6.96%)
since 12/19/25
3-Month
3.0000 +30.25%
on 12/05/25
5.0667 -22.88%
on 12/24/25
-0.9425 (-19.43%)
since 10/20/25
52-Week
1.2500 +212.60%
on 06/25/25
6.0000 -34.88%
on 02/11/25
-5.5825 (-58.83%)
since 01/21/25

Most Recent Stories

More News
NoviThera has initiated the first efficacy animal studies

BEVERLY HILLS, California, Nov. 13, 2025 (GLOBE NEWSWIRE) -- NoviThera ApS (“NoviThera”), a majority owned subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”),...

NORD : 3.9075 (-2.31%)
Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats.

BEVERLY HILLS, California, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial...

NORD : 3.9075 (-2.31%)
Orocidin develops novel cGMP manufacturing process in collaboration with Syngene

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE)...

NORD : 3.9075 (-2.31%)
Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS

BEVERLY HILLS, California, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting...

NORD : 3.9075 (-2.31%)
Nordicus Partners Corporation Applies to Uplist to the Nasdaq Capital Market

BEVERLY HILLS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and...

NORD : 3.9075 (-2.31%)
Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors

Beverly Hills, California, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a business accelerator and holding company specializing...

NORD : 3.9075 (-2.31%)
Bio-Convert Receives Positive Feedback from The Danish Medicine Agency (DKMA) on its Lead Drug Candidate, QR-02 for Oral Leukoplakia

NORD : 3.9075 (-2.31%)
Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in Dogs

NORD : 3.9075 (-2.31%)
Orocidin and Syngene Partner to Accelerate Biotech Innovation

NORD : 3.9075 (-2.31%)
Orocidin QR-01 Shows a Good Safety Profile in Preclinical Toxicity Study

NORD : 3.9075 (-2.31%)

Business Summary

Nordicus Partners A/S is a financial consulting company. Its core competencies lie in assisting Danish as well as other Nordic and international companies in different areas of corporate finance activities, such as: business valuations, growth strategies, attracting capital for businesses & company acquisitions...

See More

Key Turning Points

3rd Resistance Point 4.8333
2nd Resistance Point 4.6667
1st Resistance Point 4.3333
Last Price 3.9075
1st Support Level 3.8333
2nd Support Level 3.6667
3rd Support Level 3.3333

See More

52-Week High 6.0000
Fibonacci 61.8% 4.1855
Last Price 3.9075
Fibonacci 50% 3.6250
Fibonacci 38.2% 3.0645
52-Week Low 1.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar